Abstract |
The most abundant substance in the urinary free steroid fraction of patients with primary aldosteronism has been identified as 18-hydroxycortisol. 18-hydroxycortisol is very likely an adrenocortical secretory product rather than a peripheral metabolite, since it is abundantly synthesized by aldosteronoma tissue slices. The biogenesis of 18-hydroxycortisol takes place from cortisol rather than from 18-hydroxycorticosterone; that is, 17 alpha-precedes 18-hydroxylation. Cortisol 18-hydroxylation appears to be unrelated to the two other types of adrenocortical hydroxylation at this position. The pathway is present to a small extent in the normal human adrenal cortex and is only moderately stimulated by ACTH. Cortisol 18-hydroxylation is markedly accentuated in two circumstances: in the aldosteronoma cell where its presence may serve to distinguish tumor from bilateral hyperplasia and in ACTH-stimulatable hyperaldosteronism where it represents the first qualitative steroid biochemical abnormality to be demonstrated and as such may be useful in diagnosis and genetic studies. The possible contribution of 18-hydroxycortisol to the severity of the clinical manifestations of mineralocorticoid excess in these two types of aldosteronism remains to be explored.
|
Authors | S Ulick, M D Chu |
Journal | Clinical and experimental hypertension. Part A, Theory and practice
(Clin Exp Hypertens A)
Vol. 4
Issue 9-10
Pg. 1771-7
( 1982)
ISSN: 0730-0077 [Print] United States |
PMID | 7139974
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Aldosterone
- 18-hydroxycortisol
- Hydrocortisone
|
Topics |
- Adenoma
(metabolism)
- Adrenal Cortex
(metabolism)
- Aldosterone
(metabolism)
- Humans
- Hydrocortisone
(analogs & derivatives, metabolism)
- Hyperaldosteronism
(physiopathology)
- Hypertension
(etiology)
|